Stay updated on Comparing Antiviral Drugs in COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Comparing Antiviral Drugs in COVID-19 Clinical Trial page.

Latest updates to the Comparing Antiviral Drugs in COVID-19 Clinical Trial page
- Check2 days agoChange DetectedSite revision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page shows a minor revision update from v3.4.0 to v3.4.1; no core trial content, outcomes, or critical information appears to be changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded a Show glossary option and updated the footer text to No FEAR Act Data; the revision is updated to v3.4.0 (from v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check38 days agoChange DetectedThe update represents a minor version bump (Revision: v3.3.4) with no visible impact on study details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page shows the revision updated from v3.3.2 to v3.3.3 and the HHS Vulnerability Disclosure link was removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision: v3.3.2 deployed, replacing v3.3.1. No visible changes to the Researcher View page or trial content.SummaryDifference0.1%

Stay in the know with updates to Comparing Antiviral Drugs in COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Antiviral Drugs in COVID-19 Clinical Trial page.